Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
SRNE.US
id: 1138

SRNE

Misleading statements about the efficacy of its drug in particular with regard to its effectiveness and sales for Covid related prevention
Case Status
Inactive Investigation
Alleged Offence
Misleading Statements
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Shock Event Date
07/01/2021
Collecting participants…

Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company, develops a portfolio of next-generation treatments for three therapeutic areas: cancer, infectious disease,an...

    Ticker
    SRNE.US
    ISIN
    US83587F2020
    CIK
    0000850261
    Sector
    Healthcare
    Industry
    Biotechnology
    Country
    USA
    Address
    4955 Directors Place, San Diego, CA, United States, 92121